ELI LILLY TO FUEL EXPANSION IN CHINA

AsiaInfo Services, March, 2008

AsiaInfo Services 03-27-2008 Eli Lilly to Fuel Expansion in China BEIJING, Mar 27, 2008 (SinoCast via COMTEX) -- US-based pharmaceutical giant Eli Lilly and Company (NYSE: LLY) prefers to cooperate with Chinese pharmaceutical manufacturers rather than launch mergers and acquisitions in the nation, said Sidney Taurel, board chairman of the company. China has become one of the fastest-growing markets for Lilly, in which it embraced an annual growth of about 28 percent in 2007.

Its sales network has covered more than 100 Chinese cities. Currently, about 20 percent of the chemical medicines Lilly sold globally is manufactured by its Chinese partners. It will attach more importance to the Chinese market, especially the in the diabetes field. About four million to five...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here